Roche's Floodlight Open smartphone app for MS patients works to create a clear view into each patient’s disease while gathering real-world data.

Lyophilization Services of New England already has four facilities in the U.S. but has now jumped the Atlantic to pick up its first location in Europe.

AstraZeneca is rolling with a series of trial wins for Calquence in CLL. Will those data help the drug challenge Imbruvica’s blockbuster sales?

P&G, the packaged goods giant that bought Merck KgAA’s consumer unit, is out in force at Lions Health. Is that a message for rivals?

Three years after purchasing Medivation for $14.3 billion, Pfizer is back with another hefty M&A deal. And once again, it's betting on oncology.

Thousands of cities have sued opioid drugmakers for an alleged role in a nationwide epidemic, and lawyers have pitched a new negotiation process.

Think big. Like saving-the-world big. That's the advice McCann Health’s chief creative, Matt Eastwood, offered healthcare marketers Monday.

Boehringer Ingelheim has invested €225 million on inhaler production with a new plant in Spain and expanded lines in Germany.